We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 10.2% in the 4th quarter, Holdings Channel reports. The fund owned 8,343 shares of ...

Citizens JMP analyst Greg Miller raised the firm’s price target on GDS Holdings (GDS) to $40 from $35 and keeps an Outperform rating on the ...

Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price objective decreased by HC Wainwright from $9.00 to $8.00 in a ...

Pharmaceuticals Analysts discusses Hypothalamic Obesity Grand Rounds Ahead of Rhythm’s Phase 3 Data (RYTM) on an Analyst/Industry conference ...

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Analysts expect the Austin, Texas-based company to report quarterly earnings at 2 cents per share, versus a year-ago loss of ...

We recently published a list of 12 AI Stocks on Wall Street’s Radar Today. In this article, we are going to take a look at ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

Still, analysts expect Unity's revenue to be down 2% this year before growing 10% in 2026. If the new ad network and game ...

Q4 2025 Earnings Conference Call March 12, 2025 4:30 PM ETCompany ParticipantsDoug Clark - VP, IRTomer Weingarten - ...

Zevra Therapeutics, Inc. ( NASDAQ: ZVRA) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Nichol Ochsner - VP, IR and Corporate Communications Neil McFarlane - President and CEO LaDuane ...